{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"116"},{"groupId":"OG001","value":"11"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"116"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"description":"Number of participants who had experienced at least one treatment emergent AEs.","groups":[{"description":"PCI-32765: 420 mg daily or 840 mg daily","id":"OG000","title":"PCI-32765"},{"description":"Food-Effect Relapsed/Refractory participants received PCI-32765 420 mg daily","id":"OG001","title":"Food Effect"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"From first dose to within 30 days of last dose of PCI-32765","title":"Number of Participants With Treatment Emergent Adverse Events (AEs)","type":"PRIMARY","unitOfMeasure":"Participants"}